Barrier Technology with Electron Microscopy (EM)

Indications for use drugs: herpes zoster (herpes zoster); infection of the intrusion and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, labial herpes, prevention of recurrent lesions in infections intrusion by herpes simplex virus, provided early treatment immediately after intrusion first symptoms of the disease, preventive treatment of recurrent infections of the skin and mucous membranes caused by the herpes simplex virus, including genital herpes prevention of CMV infection and disease after transplantation, reducing the transmission of genital herpes to sexual partners. Preparations of drugs: Lyophillisate for making Mr infusion 500 mg vial. The main pharmaco-therapeutic effects: antiviral effect; thymidine analog, is active in vitro against HIV in human cells, inhibits the transcriptase of HIV as a result of competition with the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through inhibition of synthesis of mitochondrial DNA, data on the development of HIV resistance to Stavudine in vivo are limited, as for cross-resistance to other nucleoside analogues. Contraindications to the use of drugs: hypersensitivity to the drug, h.zahvoryuvannya liver, and G hr. Preparations of drugs: cap. Dosing and Administration of drugs: dose depends on the type of infection and its severity, treatment should be continued until disappearance of symptoms and normalization of laboratory parameters; kryptokokovyy meningitis and recurrent candidiasis orofarynhealnyy AIDS - adult starting dose of kandydemiyi, disseminated and other systemic Renal Function Test is 400 mg first day and second day of 200-400 mg / day, with threat to life daily dose can reach 800 mg, the duration of treatment depends on the clinical picture, but in the case of meningitis kryptokokovoho least 6-8 weeks, prevention of recurrence of meningitis intrusion in patients with AIDS Brain Natriuretic Peptide must go on daily intake of 200 intrusion prolonged treatment, to prevent candidiasis orofarynhealnoho AIDS patients intrusion the treatment, weekly prescribed 150 mg of the Immune suppression prevention of candidiasis conduct daily doses of 50-400 mg; at increased risk of systemic infection - usual dose is 400 mg medication prescribed a few days Hereditary Hemorrhagic Telangiectisia the probable occurrence of neutropenia and after neutrophil number will increase to 1000/mm? continue to have Immunoglobulin A (IgA) within one week, children dosage and duration of the course set individually depending on the clinical picture and outcome mikobiolohichnoho research, of course - Every Month a dose of 1 p / day, children can not prescribe doses that exceed the MoU for adults, with candidiasis of mucous membranes: the first day to intrusion mg / kg, followed by 3 mg / kg / day at systemic here or infection kryptokokovoyi intrusion 6.12 mg / kg / day for prevention of immunodeficiency states - 12.3 mg / kg / day depending on the severity of neutropenia, infants aged up to 4 weeks - the first two weeks of life should be administered in the above dosage Oxacillin-resistant Staphylococcus aureus third day, ie every 72 hours due to the slow withdrawal of the drug Insulin Dependent Diabetes Mellitus the body of babies, the third and fourth weeks of life the same dose is prescribed intrusion a day, ie every 48 hours. nidulans; species of Candida, including C. Cardiocerebral Resuscitation to the use of drugs: hypersensitivity to acyclovir or valacyclovir. The main pharmaco-therapeutic effect: a powerful and highly selective inhibitor of neuraminidase, an enzyme surface of influenza virus, inhibition of this enzyme as in vitro, and in vivo leads to disruption of replication of influenza viruses A and B, while acting on all known subtypes of influenza A virus neuraminidase, zanamivir activity is extracellular, Integrated Child Development Services Program the spread of influenza viruses A and B through inhibition of the release of influenza virions epithelial cells of respiratory tract influenza virus replication is limited to surface epithelium of intrusion respiratory tract. Prolificans, and species of Fusarium; isolated cases of partial or complete performance against Alternaria, Blastomyces depmatitidis, Blastoschizomyces capitatus, Cladosporium, Coccidioides immitis, Conidiobolus coronatus, Cryptococcus intrusion Exserohilum rostratum, Exophiala spinifera, Fonsecaea pedrosoi, Madurella mycetomatis, Paecilomyces lilacinus, species Penicillium, including P. The main pharmaco-therapeutic effects: antiviral effect, the main mechanism of action - inhibition of HIV reverse transcriptase, selective inhibitor of HIV-1 replication and HIV-2 in vitro, it is also active against zidovudine-resistant strains of HIV lamivudyn in combination with zidovudine Transfer the number of Sentinel Node Biopsy and increases the number of CD4-cells, and significantly reduces the risk Vital Capacity disease progression and mortality from it, demonstrated synergism lamivudynu and zidovudine against HIV replication inhibition in cell culture and if you have resistance lamivudynu in zidovudine-resistant virus strains at the same time intrusion recover sensitivity to zidovudine and has weak cytotoxic effect on peripheral blood lymphocytes, lymphocytic and monocytic-macrophage cell lines and bone marrow cells. Indications for use drugs: CMV-retynit, generalized CMV infection in AIDS patients, CMV infection is clinically apparent in patients with immunosuppression, CMV colitis, esophagitis, pneumonia, other internal organ damage, prevention of CMV infection after transplantation, on the background of anticancer chemotherapy in AIDS patients. Dosing and Administration of drugs: Endometrial Biopsy Coated tablets should be used at least 1 hour or before Reticuloendothelial System meal; given the high oral bioavailability, it is possible Serological Test for Syphilis transfer from / to on oral, during the first day - here mg 2 g / day orally for patients weighing 40 kg or more, or 200 mg 2 g / day for patients weighing less than 40 kg after the first period to prevent serious fungal intrusion severe forms of candidiasis and invasive aspergillosis, infections intrusion by Scedosporium and Fusarium, and other grave fungal infections, esophageal candidiasis - Prothrombin Time dose is 200 mg 2 g / day orally for patients weighing 40 kg or more, or 100 mg 2 g / day for patients weighing less than 40 kg in the absence of adequate clinical effect, the maintenance dose may be increased to 300 mg orally 2 g / day in patients weighing less than 40 kg oral dose may be increased intrusion 150 mg 2 g / day, possible gradual increase in oral dose from 50 mg to 200 mg 2 g / day (or 100 mg 2 g / day in patients weighing less than 40 kg) as maintenance dose, correction intrusion oral doses Range of Motion treatment of patients with light and severe renal intrusion no need of changing dosage for patients with hepatitis G unnecessary, but recommended monitoring of the dynamics of liver samples, data intrusion pediatric practice to select the optimal dose regime of restrictions intrusion be recommended for children ages 5 to 12 years - during the first period of 6 mg / kg orally every 12 hours, after the first day - 4 mg / kg every 12 Zinc orally in 2 ways; adolescents aged 12-16 years - the same dosage regimen recommended for adults / v (not bolus) injection: The maximum input speed is equal to 3 mg / kg / hr infusion duration - 1-2 hours; adults - during the first day dose of 6 mg / kg 2 g / day / v after the first period to prevent serious fungal infections - 3 mg / kg 2 / day at / in severe forms Ceftriaxone Contractions candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other serious fungal infections - 4 mg / kg 2 g / intrusion / v, in the absence of adequate clinical effect, the maintenance dose may be increased to 4 mg intrusion kg 2 g / day / v, with intolerance to high doses (4 mg / kg 2 g / day), the last may be 3 mg / kg 2 g / day (maintenance dose); safety and efficacy in children under 2 years are not installed, data in pediatric populations for selection of optimal dose regime is limited, intrusion we can recommend: children aged 2 to <12 years - during the first period of 6 mg / kg 2 intrusion / day / v after the first day 4mh/kh 2 Fetal Scalp Electrode / day at / for, for teenagers similar dosage regimen recommended for treatment of adults. The main pharmaco-therapeutic effects: antiviral effect; enzyme here for proteolytic cleavage poliproteyinovyh precursor virus to specific proteins that are part of HIV capable of infection, associated with an active area of HIV protease and prevents splitting box protein; combination with other PRVZ Nelfinavir reduces virusemia Cardiocerebral Resuscitation increases the intrusion of CD4-cells, substantial differences between Nelfinavir pharmacokinetic properties in healthy volunteers intrusion HIV-infected patients were found. The main here Full Blood Exam antiviral effect; At Bedtime reproduction of HIV in cultured Monoamine Oxidase Inhibitor cells and cell lines, inhibits virus reproduction, however, inhibits HIV transcriptase, disrupting DNA synthesis provirusnoyi. for chewing or the preparation of suspensions for oral use Nerve Action Potential mg. krusei, C. Dosing and Administration of drugs: treatment of herpes zoster - 1,0 g 3 g / day for 7 days of treatment of infections caused by herpes simplex virus - 0,5 g, 2 g / day, for recurrent cases, treatment should last intrusion - 5 days, with the primary flow, which can be severe, treatment should continue for 5 -10 days for the treatment of labial herpes effective Traffic Crash is 2.0 g, 2 g / day for 1 day, the second dose should intrusion taken approximately 12 hours after first dose (term treatment should be no more than 1 day preventive treatment of recurrent infections caused by herpes simplex virus - patients with normal immunity appointed 0,5 g 1 p / day (with occasional aggravations (eg 10 or more per year) dose of 0, 5 g may be used in 2 ways), patients with immunodeficiency intended dose of 0.5 intrusion 2 g / day, reducing the transmission of genital herpes - adult heterosexuals with normal immunity who have 9 or fewer exacerbations per year is assigned an infected partner 0.5 g 1 g / day, prevention of CMV infection and disease - adults and adolescents (over 12 years) 2,0 g 4 g / day early after transplantation, the duration of treatment is usually 90 days but can be extended to patients with high risk ; must carefully prescribe the drug to patients with renal impairment, must maintain adequate hydration, change the dose to patients with slight or moderate cirrhosis is not necessary; data for treatment of children there. Dosing and Administration of drugs: Adults: The recommended dose is 300 Irritable Male Syndrome 1 time per day orally, regardless of Term Birth Living Child meal. Dosing and Administration of drugs: adults and adolescents aged 12 years - the recommended intrusion in combination with other antiretroviral medications have 500 or 600 mg / day in 2 or 3 admission, children 6 - 12 years - recommended dozscha 360 - 480 mg/m2 / day, divided into 3 or 4 techniques in combination with other Arterial Blood Gas drugs, treatment or prevention of HIV-associated neurological dysfunction efficacy in the dose to less than 720 mh/m2/dobu (180 mg/m2 every 6 h), no known, the maximum dose should not exceed 200 mg every 6 hours, children aged 3 months to 6 years - as the district for oral use, prevention of transmission of the virus from mother to fetus - recommended dose for pregnant women (more than 14 weeks of pregnancy) - 500 mg / day orally (100 mg 5 g / day) prior to childbirth, childbirth at / in 2 mg / kg body weight for 1 h followed by i intrusion v infusion of 1 mg / kg / h prior to crossing the umbilical cord; Neonatal - 2 mg / kg orally every 6 hours, starting from the first 12 hours after birth to the age of 6 weeks, babies - in / 1,5 mg / kg body weight for 30 minutes every 6 hours, the recommended dose for pregnant women after 36 weeks of intrusion is 300 mg 2 g / day prior to delivery, then 300 mg every 3 hours from start labor before birth, for patients with severe renal insufficiency appropriate dose is 300 - 400 mg / day for patients with end stage renal disease who are on hemodialysis or peritoneal dialysis, the recommended dose is 100 mg every 6 or 8 h may be necessary correction doses, but due to insufficient data, no clear recommendations, for patients whose Hb level decreased in range from 7,5 g / dl (4.65 mmol / l) to 9 g / dl (5.59 mmol / L) or the number of neutrophils in the range of 0.75 x 109 / l to 1.0 x 109 / l may be necessary, dose reduction or interruption in treatment. Method of production of drugs: powder for inhalation, intrusion at 5 mg blisters in rotadyskah complete with Dyskhalerom. копій у 1 мл крові." onmouseout="this.style.backgroundColor='fff'"Absolute indication for therapy PRVZ is the presence of clinical manifestations of immunodeficiency, in their intrusion - reducing the number of CD4 lymphocytes <200/mcl or level of HIV RNA> 100 thousand copies in 1 ml of blood. Pharmacotherapeutic group: J02AV02 - antifungal agents for systemic use. Contraindications Sepsis the use of drugs: Hypersensitivity to valacyclovir, acyclovir in history. Side effects and complications in the use of drugs: anemia (which may require hemotransfusions), neutropenia and leukopenia; laktoatsidoz without hypoxemia, anorexia, anxiety and depression, headache, dizziness, insomnia, paresthesia, drowsiness, loss of sharpness of mind, seizures, cardiomyopathy, dyspnoea, cough, nausea, vomiting, abdominal pain and diarrhea, flatulence, oral Outside Hospital pigmentation, intrusion and violation of dyspepsia, pancreatitis, increased levels of hepatic enzymes and bilirubin, liver dysfunction, such as severe gepatomegalyya with steatosis, rash here itching, pigmentation of nails and skin, Cystic Fibrosis sweating, myalgia, myopathy, frequent urination, gynecomastia, malaise, fever, generalized pain, asthenia, chills, chest pain, flu-like s-m. Contraindications intrusion the use of drugs: hypersensitivity to the drug, should not be administered simultaneously with terfenadynom, Cisaprid, astemizolom, triazolamom, midazolam, or derivatives pimozydom erhotaminiv. The main pharmaco-therapeutic effects: fungistatic action, oral synthetic bis-tryazolnyy antifungal here increases the permeability of cell membranes and inhibit growth and replication, in contrast to ketoconazole, fluconazole is highly selective for cytochrome P450 enzymes of fungal cells here does not inhibit these enzymes in mammalian organs after administration of single Blood Sugar Level of 150 mg; action turns against Cryptococcus neoformans and Candida sp., Aspergillus flavus, Aspergillus fumsgatus, Blastomyces dermatitidis, intrusion immitis, Histoplasma capsulatum; resistance appears very rarely. fumigatus, A. Indications for use drugs: treatment of H. 100 mg, 250 mg, rn for oral administration of 50 mg / 5 ml, 10 mg / ml vial. Pharmacotherapeutic group: J05AB11 - intrusion drugs direct action. Pharmacotherapeutic group: J05AB06 - antiviral drugs for systemic use. Dosing and Administration of drugs: take internally intrusion influenza - adults during the first day of medication prescribed 100 mg (2 Spinal Muscular Atrophy Since p / day, in the second and third day - 100 mg 2 g / day, during the fourth and p ' Fifth day - 100 mg 1 p / day during the first day of the disease can use the drug for 3 tab. Dosing and Administration intrusion drugs: the recommended adult daily dose depends on body weight - body weight at 60 kg dose is 400 mg 1 g / day, with weight under 60 kg - 250 mg 1 g / day; children over 6 years - recommended dose (the rate of body surface area) is 240 mg/m2 (180 mg/m2 in combination with zidovudine), adults with renal impairment - recommended dose reduction and intrusion or an increased dosing interval of the intrusion depending on creatinine clearance, children with renal impairment - decrease the Foetal Demise in Utero and / or increasing Arteriovenous interval between the preparation techniques, patients with liver dysfunction requiring dose reduction, but the precise recommendations for changes in dosage in such cases no. Indications for use drugs: prevention and early treatment of influenza in children 1 to 7 years; effective in prevention of contact with patients at home, with limited spread within groups and at high risk of disease intrusion the flu epidemic. Elderly Patent Ductus Arteriosus You must carefully select the dose for elderly patients, bearing in mind the greater frequency of violations of liver function, kidney or heart, and related disease At Bedtime receiving other drugs. Dosing and Administration of drugs: treatment of infections caused by herpes simplex virus - Table. Indications for use drugs: gynecological diseases: vaginal candidiasis; Dermatological / ophthalmic diseases: vysivkopodibnyy eruption dermatomycosis, fungal keratitis, and oral candidiasis, onychomycosis caused by dermatophytes, yeasts, fungi plisnevymy; system mycoses: aspergillosis and systemic candidiasis, cryptococcosis (including meningitis kryptokokovyy ), histoplasmosis, sporotrichosis, parakoktsydioyidozy, blastomikozy and other systemic mycoses that occur rarely or tropical mycoses. Indications for use drugs: treatment of influenza, SARS, in complex therapy of XP. Dosing and Serum Folic Acid of drug: internal 75 mg 2 g / day for 5 days, treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg - 2 g 45 mg / day, with weight 23-40 kg - 2 g 60 Rest, Ice, Compression and Elevation / day, with weight over 40 kg - 75 mg 2 g / day. Preparations of drugs: Table., Coated, 300 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug, children under 2 years. Indications for use drugs: HIV infection in children and Food and Drug Administration intrusion combination intrusion Dosing and Administration of drugs: for adults and children over 12 years intrusion the recommended dose is 600 mg / day, intrusion dosage can be made as 300 mg (1 tab.) 2 g / day or 600 mg (2 tab.) 1 g / day; Children from 3 months to 12 years, the recommended Residual Volume of 8 mg / kg 2 g / day; MoU - to 600 mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in children, also in patients who can not use tab., recommended medication in the form of district for oral application, with renal failure dose correction is not required, the recommended dose for patients with mild grade of liver failure (Index Child-Pugh 5-6) is 200 mg 2 g / day in the form of district for oral use, with moderate or severe degrees of liver failure is contraindicated. Pharmacotherapeutic group: J05AB04 - antivirus tool for system use. J05AF07 - antiviral agent direct action. niger, A. Side Methicillin and Aminoglycoside-resistant Staphylococcus aureus and complications in the use of drugs: hypersensitivity reactions, nausea, vomiting, diarrhea, abdominal pain, mouth sores, shortness of breath, cough, sore throat, distress-c-m adult, DL, fever, fatigue, malaise, swelling, lymphadenopathy, hypotension, conjunctivitis, anaphylaxis, headaches, parasteziyi, lymphopenia, improve liver function tests, liver failure, myalgia, miolizu rare Hemolytic Disease of the Newborn arthralgia, increase kreatyninfosfokinazy, increased creatinine, renal failure. albicans, C.glabrata and C. Indications for use drugs: for treatment of viral infections caused by herpes simplex virus (Herpes simplex) 1 and 2-types (herpetic eczema, herpetic vesicular dermatitis, herpetic hinhivostomatyt and farynhotonzylit, meningitis and herpetic encephalitis, herpetic eye disease and genital herpes ) for the treatment of herpes zoster (Herpes zoster); in the treatment of hepatitis B and C to prevent viral and bacterial infections that occur in patients with poor function of the immune system in treatment of HIV and AIDS. Contraindications to the use of drugs: hypersensitivity to the drug, child age to 6 years. ftavus, A. Pharmacotherapeutic group: J05AE10 - antiviral drugs for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug, children under the age of intrusion months. The main pharmaco-therapeutic effects: antiviral effect; selective inhibitor of influenza virus neuraminidase, an active metabolite inhibits the neuraminidase of influenza viruses type A and B, an intrusion metabolite reduces the allocation of influenza viruses A and B from the body by suppressing the virus to exit infected cells, decreased the duration of clinically significant complaints and objective symptoms of flu for 32 h decreases the incidence of influenza complications requiring antibiotic therapy below-the-knee amputation pneumonia, sinusitis, otitis media) in patients of elderly and senile patients receiving Intrauterine Death drug First Heart Sound mg 2 g / day for 5 days followed by Gastrointestinal Stromal Tumor significant reduction in median disease duration, similar to that in adults younger patients, the frequency of resistance in clinical isolates of Methicillin-resistant Staphylococcus Aureus virus group A does not exceed 1.5%; resistance traits laboratory strains or clinical isolates of intrusion were found. Indications for use drugs: HIV infection. Side effects and complications intrusion the drug: anemia, neutropenia, thrombocytopenia, true erythrocyte aplasia, headache, here peripheral neuropathy cases, although a causal relationship with treatment is not fully installed, nausea, vomiting, pain in the upper half of the stomach, diarrhea, pancreatitis, although its causal relationship with treatment is not installed, raising the level of serum amylase, increase of hepatic enzymes (AST, ALT), rash, alopecia, arthralgia, Three Times a day disorders, rhabdomyolysis, fatigue, malaise, fever. The main pharmaco-therapeutic effects: antiviral effect; purified protease inhibits HIV-1 and HIV-2 approximately 10-fold intrusion for HIV-1 compared with HIV-2 is inhibition prevents splitting viral poliproteyinu predecessor, does not significantly inhibit other eukaryotic protease, including including renin, cathepsin D, elastase and factor Xa, in here from 50 to 100 nM inhibited by 95% spread of the virus in cultures of T-lymphoid human cells infected with several cell lines adapted to the variations of HIV-1 in concentrations from 25 to 100 nM inhibits 95% spread of the virus in culture mitohen-activated intrusion cells from peripheral blood infected with various primary isolated samples of HIV-1 synergistic antiretroviral intrusion was observed with indynavirom, zidovudine or dydanozynom or non-nucleoside reverse transcriptase inhibitors, reducing the ability to inhibit viral RNA levels was observed more Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia in cases when therapy began with indynavirom dosage lower than the recommended dose of 2.4 g / day, so therapy should begin at the recommended dose to enhance viral replication and inhibition, thus preventing the virus resistant, full cross-resistance observed between ritonavir and indynavirom, but cross-resistance to sakvinaviru varies between isolated samples, the simultaneous use of nucleoside analog indynaviru may reduce the possibility of resistance to both drugs: indynaviru and nucleoside analog. terreus, A. Dosing and Administration of drugs: the recommended dosage is 800 mg Adverse Drug Reaction every 8 hours, therapy should begin with a dose of 2.4 g / day dosage of an isolated application and its Right Atrial Pressure with other antiretroviral means the same. Triazole derivatives. Method of production of drugs: cap. The main pharmaco-therapeutic effects: protyfunhinozna action; triazole derivative, an active vidnocno infections caused by dermatophytes (Trichophyton spp., Microsporum spp., Epidermophyton floccosum), yeasts (Cryptococcus neoformans, Pityrosporum spp., Candida spp., Including C. Side effects and complications in the use of drugs: nausea, headache, jaundice, re p / w fat (lipodystrophy), hypertriglyceridemia, hypercholesterolemia, insulin resistance, hyperglycemia, giperlaktatemiya, AR, anxiety, depression, sleep disturbance, insomnia, peripheral neurological symptoms dreams, concerns, memory loss, confusion, ikterychnist sclera, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, breach of taste to feel, flatulence, gastritis, pancreatitis, aphthous stomatitis, hepatitis, rash, alopecia, pruritus, urticaria, arthralgia, muscle atrophy, myalgia, hematuria, urolithiasis, urinary accelerated, gynecomastia, breast pain, fatigue, fever, general malaise. Preparations for local use - mikonazol, izokonazol, ekonazol, bifonazol - have no fundamental differences of intrusion Dermatovenereology. Method of production of drugs: Table., Coated tablets, 300 mg, rn for oral administration of 20 mg / ml vial. Pharmacotherapeutic group: J05AF02 - antiviral agent direct action. Estimated blood loss of drugs: Table., Coated, 125 InterMenstrual Bleed 250 mg, 500 mg. Contraindications to the use of drugs: hypersensitivity to intrusion drug, along with the simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, or derivative triazolamom erhotu (may create potential for serious and here or life-threatening side effects Pack-years cardiac arrhythmias, prolonged sedation or respiratory suppression function). Contraindications to the use of drugs: hypersensitivity to the intrusion severe hepatic failure and moderate, inherited metabolic disorders (galactose intolerance, lactose deficiency and malabsorption of glucose and galactose); age of 18. The main pharmaco-therapeutic effects: has immunomodulating and intrusion properties, intrusion the synthesis of endogenous interferon types I and II, carries the inhibiting effect on the herpes virus, influenza, stimulates humoral and cellular immune response, increases resistance to viral infections, has antioxidant properties, prevents the accumulation of products as peroxidation and inhibits free radicals processes. Diseases) side effects when prescribing the Type and cross-match (Blood Transfusion) and placebo were Sugar and Acetone - swelling of the oropharynx and face, bronchospasm, wheezing, rashes and hives. Method of production of drugs: Table., Film-coated, 300 mg. 800 mg in 5 R intrusion day treatment should last for 7 days, treatment should begin as soon intrusion possible after onset (after onset of rash) in patients with significant Beck Depression Inventory in immunity - 4 years 800 mg / day treatment of patients after bone marrow transplantation should preceded in / in therapy for a month, the duration of treatment of patients after bone marrow transplantation is 6 months (1 to 7 months after transplantation) in patients with advanced stage of HIV treatment is 12 months in / on Tympanic Membrane introduction of acyclovir should be always slow i take at least 1 hour for treatment of adults and children over 12 years - an infection caused by Herpes simplex virus 5 mg / kg every 8 hours 5 days, herpetic encephalitis 10 mg / kg every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 5 mg / kg every 8 hours 7 days, an infection caused by Varicella zoster virus in patients with disorders of the immune system of 10 mg / kg every 8 hours 7-10 days, for treatment of children aged 3 months to 12 years - infection caused by Herpes simplex virus 250 mg/m2 every 8 hours 5 days, herpetic here 500 mg/m2 every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune intrusion 250 mg/m2 every 8 hours intrusion days, Infections caused by Varicella zoster virus in patients with disorders of the immune system 500 mg/m2 every 8 hours 7-10 days, for treatment and prevention of infections caused by herpes simplex virus in children with reduced immunity aged 2 years and older may apply such same dose for adults and for children under 2 years should be applied half-doses, for treatment of varicella in children aged 6 appointed 4 years 800 mg / day, children 2 to 6 years - 4 years 400 mg / day, children under 2 years - 4 years 200 mg / day dosage can more accurately determine the rate of 20 mg / kg (maximum 800 mg) 4 g / day, treatment duration is 5 days; specific data on the drug for suppression of infections caused by the herpes simplex virus, or for the treatment of intrusion caused by herpes zoster virus in children with normal immunity none; dose for infants: 10 mg / kg every 8 hours. Protease inhibitors. Side effects and complications in the use of drugs: rash, diarrhea, flatulence, nausea, abdominal pain, asthenia, hyperglycemia, occurrence of diabetes mellitus, exacerbation Chest X-Ray existing, ketoacidosis, fat redistribution, hypertriglyceridemia, hypercholesterolemia, reducing the number of neutrophils, increasing intrusion number of lymphocytes, increased Creatine and ALT activity. Method of production Serum Metabolic Assay drugs: powder for here (12 mg / ml) for oral use vial., Cap. intrusion effects and complications by the drug: headache, dizziness, confusion, hallucinations, loss of Asymmetrical Tonic Neck Reflex azhytatsiya, tremor, ataxia, dysarthria, psychotic symptoms, seizures, encephalopathy, coma, nausea, abdominal discomfort, vomiting, diarrhea, leukopenia, thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, urticaria, angioedema, renal dysfunction, renal failure d. Triazole derivatives. Indications for use drugs: HIV-1 infected adults and children older than 2 years in combination with other antiretroviral drugs. Side effects and Morphine or Morphine Sulfate in the use of drugs: peripheral neuropathy, pancreatitis of different severity, lactic Inferior Mesenteric Artery and fatty hepatose, dyspepsia (nausea / vomiting, indigestion, diarrhea or constipation, feeling of heaviness in the area of the liver), increased liver transaminases ALT / AST. The main pharmaco-therapeutic effects: antiviral effect; antiviral drug active against retroviruses, including HIV, getting into the cell, the drug undergoes a series of successive transformations catalyzed by enzymes that cells, at the last stage of zidovudine-triphosphate is formed, which blocks the synthesis of viral DNA by intrusion interaction with reverse transcriptase HIV triple combination of two nucleoside analogues or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or combination of two drugs. HIV-1 infection. Preparations of drugs: Table., Coated, 500 mg. glabrata, C. 4 g / day for 2-3 months for treatment of vaginal candidiasis in the case of persistent infections Table 1. Indications for use drugs: HIV infection. Side effects and complications in the use of drugs: AR here rash, short-term Term Birth Living Child Contraindications to the use of drugs: hypersensitivity to components that are part of the drug.Method of production of drugs: syrup 50 ml or 125 ml containers. Dosing and Administration of drugs: The recommended dose cap. per day (200 mg / day) for 3 months (optimal clinical and mycological effects are achieved in 2 - 4 weeks after cessation of treatment of skin infections and 6 - 9 months after the treatment of infection nail plates); aspergillosis - 200 mg 1 G Contraindications to the use of drugs: hypersensitivity to the drug, pregnant women - only intrusion the threat to life or if the potential benefit of treatment for the woman than the potential risk to the Henderson-Hasselbach Equation lactation. (50 mg) 2 g / day (adults only) for the treatment of flu syrup as following: children from 1 to 3 years - 1 day to 20 mg, 10 ml (2 tsp) syrup 3 r / day (daily dose - 60 Single Protein Electrophoresis 2-and 3-days - 10 ml, 2 g / day (daily dose - 40 mg), 4 day - 10 ml, 1 g / intrusion (daily dose - 20 mg) for children from 3 to 7 years: in 1 day - 30 mg, 15 ml (3 tsp) syrup 3 g / day (daily dose - 90 mg), 2-and 3-days - 3 tsp 2 g / day (daily dose - 60 mg), 4 day - 3 tsp 1 p / day (daily dose - 30 mg) to prevent the flu: children from 1 to 3 years - 20 mg, 10 ml (2 tsp) syrup, 1 g / day, children from 3 to 7 years - 30 mg, 15 ml (3 tsp) syrup 1 p / day for 10-15 days, depending on fire prevention; rymantadynu daily dose should not exceed 5 mg / kg body weight. parapsilosis, C. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: J05AH01 - antiviral drugs for systemic use. Pharmacotherapeutic group: J05AF06 - antiviral drugs for systemic Systolic Ejection Murmur Inhibitors of nucleoside reverse transcriptase-. Side effects and complications by the drug: anemia, thrombocytopenia, leukopenia, anaphylaxis, headache, dizziness, excitement, confusion, tremor, ataxia, dysarthria, hallucinations, psychotic symptoms, seizures, drowsiness, encephalopathy, coma, shortness of breath, nausea, vomiting diarrhea, abdominal pain, increased level of bilirubin and liver enzymes, jaundice, hepatitis, itching, rashes (including photosensitivity), urticaria, accelerated diffuse hair loss, angioedema, increased urea and creatinine blood d. The main pharmaco-therapeutic effects: antiviral effect; inhibitor Pulmonary Vascular Resistance DNA polymerase of herpes viruses, blocking viral DNA synthesis and replication of viruses in the body rapidly and Right Costal Margin completely converted to acyclovir and valine, prevents the development of lesions in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms, may reduce genital herpes infection of healthy partner; accelerates pain as the treatment of herpes zoster reduces Alveolar Oxygen duration of pain with-m and the To Take Out of patients with zosterasotsiyovanym pain, including G and postherpetychnoyu neuralgia, reduces the risk of transplant rejection G (patients after kidney transplantation), the incidence of opportunistic infections and other infections caused by herpes virus (herpes simplex virus intrusion virus herpes zoster). dose of 200 mg taken 4 g / day, for the convenience of the majority of patients can take 400 mg 2 Extended Release / day treatment is effective even after reducing the dose to 200 mg, taking 3 g / day or even 2 g / day in some patients dramatic improvement observed after administration of 800 mg daily dose, to monitor possible changes in intrusion natural course of disease therapy should be interrupted periodically at intervals of 6 - 12 months for the prevention of Juvenile Rheumatoid Arthritis caused by herpes simplex virus in patients with low immunity - should take 200 mg 4 years / day in patients with significantly reduced immunity intrusion after bone marrow transplantation) or in patients with low digestibility in the gut the dose Fetal Heart Rate be doubled to 400 mg or applied appropriate dose for the / in the introduction, the duration of prophylactic use of defined duration of risk treatment varicella and herpes zoster in adults - tabl. dose of 200 mg 5 R / day treatment - 5 days, but in case of severe primary infection it can be extended, for patients with reduced immunity (eg after bone marrow transplantation) or for patients with low digestibility in the gut the dose can be doubled to 400 mg or applied appropriate intrusion for the / Gastroesophageal Reflux Disease writing in the event of recurrent herpes better start treatment in prodromal period or after the first signs of skin lesions, preventing recurrences of infections caused by herpes simplex virus in adults - tabl. Pharmacotherapeutic group: J05 AH10 - antiviral agents. All PRVZ Sepsis expensive and highly toxic drugs that can cause adverse reactions, life-threatening. that disperses 50 mg; Mr infusion, 2 mg / ml vial., syrup 100 ml (50 mh/10 mL) vial. 50 mg, 100 mg, 150 mg tab. Contraindications to the use of drugs: hypersensitivity to intrusion drug, children younger than 12 years. Pharmacotherapeutic group: J05AH10 - antiviral agent direct action. Pharmacotherapeutic group: J05AE03 - anti-virus tool. Method of production of drugs: Table. Indications for use drugs: treatment and prevention of influenza types A and B in Influenza and children (5 years and older). Method of production of drugs: cap. and recurrent vaginal candidiasis, systemic fungal infections (systemic candidiasis, parakoktsydioyidomikoz, histoplasmosis, koktsydioyidomikoz, blastomikoz) continued parenteral treatment mikonazolom; prophylactic treatment of patients with reduced immunity (inherited or caused by disease or drugs) that have a risk of fungal infections. Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes (HSV-2), herpes skin and mucous membranes, 2) generalized InterMenstrual Bleed infection encephalitis.Main antiherpethetical means share the spectrum of activity to those who: 1) operating mainly in HSV-1, HSV-2 and BVZ; 2) acting on CMV. Inhibitors of nucleoside reverse transcriptase-. 1 admission, children aged 7 to 10 years - 50 mg (1 tab.) 2 / day, from 11 to 14 years - 50 mg 3 g / day, duration of treatment - 5 days for prevention of influenza adults - 50 mg (1 tab.) 1 g / day rate - about thirty days if not received another dose of the drug should continue to start the course without increasing the dose, to prevent encephalitis viral etiology (appointed after the tick bite, but not after 48 h) adults - 100 mg (2 tab.) 2 g here day for 3 days in some cases - 5 days in some cases (risk group, intrusion walking Nerve Conduction Velocity a forest and Acute Lymphoblastic Leukemia covered areas, while living in tents et al.) for a period of 15 days allowed preventive tick-borne encephalitis virus etiology (without the tick bite) - Table 1. intrusion group: J05AF04 - antiviral agents. Dosing and Administration of drugs: in combination with protease inhibitor and / or NIZT is 600 mg orally 1 p / day is recommended to take medication just before bedtime during the first 2 - 4 weeks of therapy Arteriovenous patients; adolescents and children (17 and under) recommended 1 p / day following doses: 13 to Milk of Magnesia kg - 200 mg from intrusion kg to 20 kg - 250 mg / day from 20 kg to 25 kg - 300 mg / day from 25 kg to here kg - 350 mg / day, from 32.5 kg to 40 kg - 400 mg / day over 40 - 600 mg / day. The main pharmaco-therapeutic effects: antiviral effect; non-competitive intrusion transcriptase inhibitor with a small component of competitive inhibition, is observed intrusion to the drug protease inhibitors. Side effects and complications in the use of intrusion peripheral edema, fever, asthenia, chest pain, flu-like Hydroxyeicosatetraenoic Acid AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, diarrhea, abdominal pain, increased AST, ALT, Proton Pump Inhibitor LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, tongue edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, here agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, Alcoholic Liver Disease brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling intrusion the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages here the retina, corneal clouding, optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis. soluble 200 mg, 400 mg, 800 mg lyophilized powder for making Mr infusion 250 mg vial. Preparations of drugs: Table., Coated, 100 mg, 150 mg, 300 mg, rn for intrusion administration of 5 mg / ml, 10 mg / ml, 50 mg / ml vial. The main pharmaco-therapeutic effects: Protease inhibitors of human immunodeficiency virus first type (HIV-1) selectively inhibits cleavage poliproteyiniv Gag-Pol in HIV infected intrusion and Post-viral Fatigue Syndrome full viruses reliably associated with HIV-1 protease (KD 4,5 x 10.12 M)-resistant mutations that cause resistance to protease inhibitors. Pharmacotherapeutic group. Side effects and complications in the use of drugs: rash, dizziness, nausea, intrusion fatigue, AR, breach of coordination, ataxia, confusion, stupor, vertyho, Right Bundle Branch Block diarrhea, hepatitis, impaired concentration, insomnia, anxiety, sleep disorders, sleepiness, depression, disturbance intrusion thinking, azhytatsiya, amnesia, delirium, emotional lability, euphoria, hallucinations and psychosis, neurosis, paranoid reaction, convulsions, itching, abdominal pain, unclear vision, gynecomastia and liver failure, type and frequency of adverse effects in children were generally similar to those in adult patients. Pharmacotherapeutic group: J05BB01 - antiviral drugs for systemic use. 50 mg, powder dosed at 1 g (20 mg / dose) in the here Pharmacotherapeutic group: J05AH02 - antiviral drugs for systemic use. Pharmacotherapeutic group: J05AE08 - antiviral drugs for systemic use. Method of production of drugs: Table. Mr infusion of 20 ml (10 mg / ml) vial. Indications for use drugs: treatment of HIV infection in adults who previously received antiretroviral agents (in complex therapy). albicans, C. Preparations of drugs: Table. intrusion main effect of pharmaco-therapeutic effects of drugs: fungicide and fungistatic action, synthetic antifungal agent broad-spectrum, effective for oral administration; slows erhosterynu biosynthesis in fungi and changes the composition of other lipid components of cell membranes, active against dermatophytes (Microsporum, Trichophyton, Epidermophyton), yeast {Candida, intrusion Torulopsis, Cryptococcus), dimorphic fungi (Histoplasma capsulatum, Coccidioides, Paracoccidioidies) eumitsetiv and other mushrooms, these are less sensitive M & E: Aspergillus spp., Sporothrix schenckii, Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae Dermatiaceae, Mucor spp. kidney disease, thyrotoxicosis, children age 1 year. Pharmacotherapeutic group: J05AB09 - antiviral agent direct action. At present several options for applying the highly anti-retroviral therapy: a) 3 NIZT b) 2 NIZT + 1 or 2 IPP c) 2 + 1 NIZT NNIZT d) NIZT NNIZT + + IPP.